A Washington D.C.-based biotech is causing quite the stir so far during Wednesday’s premarket after the company’s Fanapt received FDA approval for the acute treatment...

To read the full story on AllPennyStocks.com, click here.

Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Vanda Pharmaceuticals Charts.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Vanda Pharmaceuticals Charts.